Robert Nelsen, Director, 10% Owner at Vir Biotechnology, Inc. (VIR), bought 12,666,665 shares at $20.00 ($20.0M) on 2019-10-16, disclosed to the SEC on 2019-10-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 11,666,665 | $0 | 0.0% |
| 2 | $20.00 | 1,000,000 | $20.0M | 100.0% |
| Total | $1.58 avg | 12,666,665 | $20.0M | 100% |
| Filing → |
| SANA | BUY | 2024-02-12 | $8.0M | — | Filing → |
| NMRA | BUY | 2023-09-29 | $2.1M | — | Filing → |
| NMRA | BUY | 2023-09-27 | $1.0M | — | Filing → |